–
Статьи в журналах
-
- 2020 Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
- Paulus Kirchhof MD, MD Sylvia Haas, MD PhD Pierre Amarenco, MD Susanne Hess, Dipl-Math Marc Lambelet, MD Martin van Eickels, Turpie MD Alexander G.G, Camm MD A.John, Matskeplishvili Simon, of the XANTUS Investigators* on behalf
- в журнале Journal of the American Heart Association, том 19, с. 1-11
-
- 2016 XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
- John Camm A., Amarenco Pierre, Haas Sylvia, Hess Susanne, Kirchhof Paulus, Kuhls Silvia, van Eickels Martin, Turpie Alexander, Matskeplishvili Simon, the XANTUS Investigators
- в журнале European Heart Journal, издательство Oxford University Press (United Kingdom), том 37, № 14, с. 1145-1153
-